Navigation Links
Potential in Medical News

Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results

... for Orexigen, and the results demonstrate the potential for Contrave to help patients in their battle ... the efficacy and safety of Contrave(R), the potential for, and timing of, an NDA submission for Contrave, the commercial and therapeutic potential of Contrave, and ...

US Oncology Reports Second Quarter Operating Results

... The most significant difference between the potential and estimated impact reflects our expectation ... of capital and credit markets, including the potential that certain financial institutions may be unable ... the Company's affiliated physician practices, and potential impairments that could result from declining ...

Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum

... MenSCs proliferate rapidly and have significant potential to develop into multiple cell types. Dr. Julie ... system, MenSCs are currently being studied for potential therapeutic applications for possible future ... the uncertainty of market acceptance of any potential service offerings relating to types of stem cells ...

Transcept Pharmaceuticals to Report Second Quarter 2009 Results

... the lead product candidate at Transcept, has the potential to be the first prescription sleep aid ... of the night awakening actually occurs, has the potential to reduce unnecessary sedative-hypnotic exposure. ... statements include, but are not limited to, the potential for Intermezzo (R) to be the first prescription ...

SXC Health solutions announces record second quarter financial results

... in accordance with GAAP, and investors and potential investors are encouraged to review the ... our ability to compete successfully; potential liability for the use of incorrect or incomplete ... capital to fund our future requirements; and potential write-offs of goodwill or other intangible ....

BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company

... that it will receive $105 million, in addition to potential milestone payments, from the sale of ... rates, and volatility in the securities markets; potential liability for uninsured losses and environmental contamination; risks associated with the company's potential failure to qualify as a REIT under the Internal ...

Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis

... Lexicon's clinical development of LX2931 and the potential therapeutic and commercial potential of LX2931. This press release also contains ... preclinical and clinical development of its other potential drug candidates, advance additional candidates ...

DURECT Corporation Announces Second Quarter 2009 Financial

... We are in active discussions with multiple potential partners regarding licensing of the U.S./Canada ... We are in active discussions with multiple potential partners regarding licensing development ... FDA comments in the Complete Response Letter, the potential of FDA approving the REMOXY NDA, the timing and ...

New microchip technology performs 1,000 chemical reactions at once

... which could accelerate the identification of potential drug candidates for treating diseases like ... chemistry, a technique often used to identify potential drug molecules that bind tightly to protein ... and accelerating the process for identifying potential drug candidates," said study author Hsian-Rong ...

Synthetic biology -- opportunities and risks

... will, in the medium term, open up a great deal of potential for combining novel genetic methods with ... and re-synthesising it. In the medium term, the potential applications of synthetic biology range from ... to outline how Germany can best profit from the potential offered by synthetic biology. These five spheres ...

MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results

... LEVADEX has a differentiated profile, with the potential to provide rapid and sustained relief of migraine ... is developing LEVADEX inhaled therapy for the potential treatment of migraine and has reported positive ... as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' ...

Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)

... we have made substantial progress toward the potential final approval of KRYSTEXXA, we also have more ... words. In particular, any statements regarding potential FDA marketing approval for KRYSTEXXA(TM) ... KRYSTEXXA; difficulties in obtaining financing; potential development of alternative or more effective ...

Advanced targeted therapies effective as first-line treatment for lung cancer

... therapies, as first-line treatment, have the potential to slow cancer growth and improve patient ... of first-line chemotherapy. To expand the potential for the use of erlotinib, Wolfram Brugger, M.D., ... "This study demonstrates the tremendous potential for erlotinib and ...

United Therapeutics Corporation Reports Second Quarter 2009 Financial Results

... highlights our mature pipeline, which has the potential for further growth through continued market ... both the outstanding grants under our STAP and a potential year-end stock option grant. Earnings ... market penetration of Remodulin, and the growth potential for Adcirca and Tyvaso. These forward-looking ...

AMERIGROUP Reports Q2 Net Income of $49.6 Million or $0.94 per Diluted Share, Including $0.43 per Diluted Share Positive Impact from Tax Adjustment

... of common shares and dilutive potential common shares outstanding ... of common shares and dilutive potential common shares outstanding ... of common shares and dilutive potential common shares outstanding ...

Solta Medical Reports Strong Second Quarter 2009 Results

... for GAAP financial measures. Investors and potential investors should consider non-GAAP financial ... products and treatments. Further information on potential risk factors that could affect Solta Medical's ... 23,743,043 Adjustments for dilutive potential common stock 447,282 313,718 ...

WebMD Announces Second Quarter Financial Results

... or updated products or services and from other potential sources of additional revenue; expectations ... and WebMD (the "Merger Transaction"); and the potential sale of Porex by HLTH (the "Potential Sale ... or whether HLTH will be able to complete the potential Sale Transaction or as to the timing or terms ...

HLTH Corporation Announces Second Quarter Financial Results

... from new products or services and from other potential sources of additional revenue; expectations ... and WebMD (the "Merger Transaction"); and the potential sale transaction with respect to Porex (the ... or whether HLTH will be able to complete the potential Porex Transaction or as to the timing or terms of ...

Cepheid Reports 2009 Second Quarter Results

... for the future, including those relating to potential growth in clinical product sales, regulatory ... on our business, and that of our customers, potential customers and business partners; our success in ... development and manufacturing problems; the potential need for additional intellectual property ...

STERIS Corporation Announces Fiscal 2010 First Quarter Results

... express or implied, will not be realized. Other potential risks and uncertainties that could cause actual ... statements include, without limitation, (a) the potential for increased pressure on pricing that leads to ... Company performance, results, or value, (d) the potential of international unrest or effects of ...

BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update

... corporate update regarding clinical programs and potential emergency use of intravenous (i.v.) peramivir in ... agencies to provide i.v. peramivir as a potential treatment option for an influenza emergency, as ... the efficacy and safety of peramivir as a potential treatment for influenza." Second Quarter ...

CareFusion Issues Update Regarding Previously Disclosed June 12, 2009 Recall of the Alaris(R) System

... to customers of its Alaris(R) System addressing potential risks identified with the Alaris System. The ... (IUI) connectors on the Alaris(R) System. The potential risks may lead to improper infusion therapy, ... an additional required action to mitigate potential risk before completion of the field corrective ...

Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America

... activities at Access, while discussions with potential licensee and co-promotion partners is ongoing. "Access is focused on maximizing the potential of MuGard, both for patients and for its ... "I have always known the substantial potential for MuGard in the prevention and treatment of ...

WellPoint Reports Second Quarter 2009 Results

... including those related to CMS sanctions, potential uncollectability of receivables resulting from ... in required minimum levels of capital and the potential negative affect from our substantial amount of ... future bio-terrorist activity or other potential public health epidemics; and general economic ...

Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe

... in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective ... aggressive NHL as determined by the FDA, the potential that the EMEA does not grant the MAA for pixantrone, the potential that priority review will not be granted by the ...

Inverness Medical Innovations Announces Second Quarter 2009 Results

... the three months ended June 30, 2009 and 2008, potential dilutive shares were not used in the calculation ... 1,527,000 common stock equivalent shares from the potential exercise of stock options and warrants. Also included were potential dilutive shares consisting of 3,416,000 common ...

QLT Announces Second Quarter Results for 2009

... plugs. We continue to strongly believe in the potential of our punctal plug delivery technology for broad ... to reversal of a provision for a potential retroactive pricing rebate on certain sales of ... to reversal of a provision for a potential retroactive pricing rebate on certain sales of ...

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results

... of LX1031, LX1032, LX2931, and LX4211 and the potential therapeutic and commercial potential of LX1031, LX1032, LX2931, and LX4211. This ... preclinical and clinical development of its other potential drug candidates, advance additional candidates ...

Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma

... de Montreal, indicate that QPI-1007 has the potential to treat patients with glaucoma. QPI-1007 is ... additional data supporting the therapeutic potential of QPI-1007 -- the first siRNA drug candidate ... optimal activity and stability while attenuating potential off-target effects." Prof. Di Polo ...

Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice

... embryonic stem cells, whose natural therapeutic potential lies in their ability to develop into the ... including the results of an in-depth analysis of potential abnormalities among the first generation of iPS ... "that some of the mouse studies will have some potential application in humans," and that this possibility ...

Scientists Use Adult Stem Cells to Create Healthy Mice

... embryonic stem cells, whose natural therapeutic potential lies in their ability to develop into the ... including the results of an in-depth analysis of potential abnormalities among the first generation of iPS ... "that some of the mouse studies will have some potential application in humans," and that this possibility ...

Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009

... (zolpidem tartrate sublingual tablet), has the potential to be the first prescription sleep aid ... the lead Transcept product candidate, has the potential to be the first prescription sleep aid ... of the night awakening actually occurs, has the potential to reduce unnecessary sedative-hypnotic exposure. ...

Quigley Corporation Announces Final Results of Quigley Pharma's Phase IIb Study

... on April 30, 2009. Those data may indicate the potential benefit of this compound as a disease modifying ... in the feet to provide more detail to the potential for disease modification. There can be no ... the entire research and development portfolio of potential products in the Quigley Pharma pipeline," said ...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration for Chronic Wound Healing Management

... efforts will be to identify and develop potential future therapeutic applications for chronic wound ... and development that will investigate the potential benefits of new ways to utilize menstrual blood ... presents an exciting opportunity to explore potential new protocols that may possibly leverage the ...

Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer

... "This outcome represents a positive signal of the potential benefit of this combination for patients with ... and 28% for placebo. Women of child-bearing potential should be advised to avoid becoming pregnant and ... commercialization efforts or commercial potential of Nexavar. These statements are subject to risks ...

Amylin Pharmaceuticals Reports Second Quarter Financial Results

... progress regarding the development and potential launch of exenatide once weekly. The FDA accepted ... the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin ... the pace of market acceptance may also affect the potential for BYETTA or SYMLIN. These and additional risks ...

Ortho Clinical Diagnostics Launches 24-Hour Remote Monitoring Center

... This innovative service detects and predicts potential instrument problems before they interrupt the ... Diagnostics. "By detecting and predicting potential problems before they occur, we are working with ... unmet need for new technologies that reduce the potential for instrument failures and workflow ...

STERIS Corporation Announces Date of Fiscal 2010 First Quarter Earnings Release and Conference Call

... express or implied, will not be realized. Other potential risks and uncertainties that could cause actual ... statements include, without limitation, (a) the potential for increased pressure on pricing that leads to ... Company performance, results, or value, (d) the potential of international unrest or effects of ...

C'elle(SM) Featured on ABC Action News in Tampa Bay

... in which women are looking to safeguard against potential future illnesses, conditions or injuries. ... self-renewing stem cells that may be stored for potential treatments in the future. A Florida-based ... proprietary cutting edge technology for a potential neurological application. Cryo-Cell ...

New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies

... investigator in the GRACE study. "GRACE has the potential to shape how future HIV studies should be ... in patients receiving PREZISTA/r . This list of potential drug interactions is not complete. ... Resistance / Cross Resistance : The potential for HIV cross-resistance among protease ...
Other Contents
(Date:9/2/2014)... the same DNA sequence their genetic information. How ... in the different parts of the body are so ... master plan, an additional regulatory layer exists that determines ... This mechanism involves modifications of genome-bound histone proteins or ... It acts on top of the genetic information and ...
(Date:9/2/2014)... battle between our immune systems and cholera bacteria, humans ... as phages. In a new study, researchers from Tufts ... Public Health Laboratory, and elsewhere, report that phages can ... order to survive. Importantly, the study published in ... from phage predation occurs during human infection. , First ...
(Date:9/2/2014)... decade in Taiyuan, China, have substantially improved the health ... 50% reduction in costs associated with loss of life ... at the Columbia Center for Children,s Environmental Health (CCCEH) ... Medical University, the Center of Diseases Control and Prevention ... Public Health. , The study is the first to ...
Breaking Biology News(10 mins):Throwing a loop to silence gene expression 2War between bacteria and phages benefits humans 2War between bacteria and phages benefits humans 3Clean air halves health costs in Chinese city 2
(Date:9/2/2014)... 2014 Today, Therapy Changes ... for Me?” The guide outlines common questions an individual ... addition to common types of groups an individual can ... from the interventions of the therapist, but also from ... group members,” says Rochelle Perper, Ph.D. and founder of ...
(Date:9/2/2014)... Atlanta, Ga. (PRWEB) September 02, 2014 ... hosted by, respectively, top-industry professionals Carey Lewis ... each person auditioning, seeking those who have the desire ... chosen for a callback, performers could be invited to ... SHINE convention. , Charlotte, NC – Saturday, Sept. 6, ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Cloud Medical ... of “Cloud Based” Medical Practice Business Operations solutions and ... of Digital Cyber Security solutions for all industries announced ... on the trading floor of the CME in Chicago ... DeLaGarza stated that we are very proud of the ...
(Date:9/2/2014)... CA (PRWEB) September 02, 2014 On ... on its website titled “Why You Should Wash Your ... 80 percent of the global population breathes air considered ... particles of pollution lodge in the skin’s pores destroying ... natural barrier to free radicals that may cause cell ...
(Date:9/2/2014)... women diagnosed with early-stage breast cancer in California, the ... and 2011, although this procedure was not associated with ... radiation, according to a study in the September 3 ... that surgery for the removal of one breast was ... other options examined in the study. , Randomized trials ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3
Other TagsOther Tags